Related Experiment Video
Updated: Sep 13, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Should Microhematuria Be Incorporated into the 2023 Duke-International Society for Cardiovascular Infectious Diseases
Jean Regina1, Louis Stavart2, Benoit Guery3
1Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Abstract:
Background/Objectives: Microhematuria is common in patients with infective endocarditis (IE). The present study aims to assess whether the addition of microhematuria in the 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) minor immunological criteria could enhance its diagnostic performance. Methods: This retrospective study was conducted at the Lausanne University Hospital, Switzerland (2014-2024). All patients with suspected IE and urinalysis within 24 h from presentation were included. The Endocarditis Team classified episodes as IE or non-IE. Microhematuria was defined as >5 red blood cells per high power field (HPF). Results: Among 801 episodes with suspected IE, 263 (33%) were diagnosed with IE. Microhematuria (>5/HPF) was present in 462 (58%) episodes, with no difference between episodes with and without confirmed IE (61% versus 56%; p = 0.223). Based on the 2023 ISCVID-Duke, minor immunological criteria were present in 42 episodes (5%). By adding microhematuria, 473 (59%) episodes met the minor immunological criteria. Sensitivity of the clinical criteria of the 2023 ISCVID-Duke version without and with hematuria was calculated at 75% (69-80%) and 86% (81-90%), respectively. Specificity was at 52% (48-57%) and 40% (36-45%), respectively. Among episodes with suspected IE, microhematuria was associated with female sex, enterococcal bacteremia, sepsis or septic shock, acute kidney injury, non-cerebral embolic events, and bone and joint infection. Conclusions: Microhematuria was frequent among patients with suspected IE, but it was not associated with the diagnosis of IE. The addition of microhematuria in the 2023 ISCVID-Duke minor immunological criteria did not enhance the overall performance of the criteria.
Insights
Microhematuria is common in infective endocarditis (IE) but does not improve diagnosis. Adding it to the 2023 Duke-ISCVID criteria did not enhance diagnostic performance for IE.
Area of Science:
- Cardiology
- Infectious Diseases
- Nephrology
Background:
- Microhematuria is frequently observed in patients with infective endocarditis (IE).
- Current diagnostic criteria for IE, such as the 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) guidelines, do not specifically incorporate microhematuria.
- The diagnostic utility of microhematuria in suspected IE cases requires further investigation.
Purpose of the Study:
- To evaluate the diagnostic performance of the 2023 Duke-ISCVID minor immunological criteria for infective endocarditis.
- To assess whether the addition of microhematuria to these criteria can enhance diagnostic accuracy.
- To identify clinical associations of microhematuria in patients with suspected IE.
Main Methods:
- Retrospective analysis of 801 patients with suspected IE and urinalysis at Lausanne University Hospital (2014-2024).
- Microhematuria defined as >5 red blood cells per high power field (HPF).
- Comparison of diagnostic performance of 2023 ISCVID-Duke criteria with and without the inclusion of microhematuria.
Main Results:
- Microhematuria was present in 58% of suspected IE cases, with no significant difference between confirmed IE and non-IE groups.
- Inclusion of microhematuria increased the proportion of patients meeting minor immunological criteria from 5% to 59%.
- Adding microhematuria improved sensitivity (75% to 86%) but decreased specificity (52% to 40%) of the 2023 ISCVID-Duke criteria.
Conclusions:
- Microhematuria is a common finding in suspected infective endocarditis but is not specifically associated with the diagnosis.
- Incorporating microhematuria into the 2023 ISCVID-Duke minor immunological criteria does not improve the overall diagnostic performance.
- Microhematuria in suspected IE is associated with female sex, enterococcal bacteremia, sepsis, acute kidney injury, and embolic events.
More Related Videos
07:24Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
Published on: October 29, 2020
11:28Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Immunofluorescence Microscopy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care